Skip to content

Analgesia Nociception Index In Pediatric Patients With Chronic Pain

Validity of the Analgesia Nociception Index in Children and Adolescents With Chronic Pain

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07145762
Acronym
Chronic pain
Enrollment
60
Registered
2025-08-28
Start date
2025-09-15
Completion date
2026-10-01
Last updated
2025-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Brief summary

The goal of this observational study is to learn about the analgesia nociceptive index (ANI) is associated with pain sensitivity in patients between the ages of 9-17 who are experiencing chronic pain. The main question it aims to answer is: \- Does the ANI score correlate with the change in the pain sensitivity in patients aged 9-17 undergoing an interventional block. Patients already receiving an interventional block as part of their regular medical care for chronic pain will have their level of pain recorded during clinic appointments

Interventions

PROCEDUREInterventional Block

For patients who are offered interventional blocks as part of their standard of care, we will measure ANI as well as pressure pain threshold before, during, and after the block as well and at follow-up to assess correlation with treatment efficacy.

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
9 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Experiencing chronic pain defined by: persistent or recurrent pain at least once a week for at least three months in their electronic medical charts or by reference of the patient's physician

Exclusion criteria

* Taking medications known to affect the sympathetic or parasympathetic nervous systems such as cholinomimetics (e.g., pilocarpine), anticholinergics (e.g., ipratropium), sympathomimetics (e.g., salbutamol), and adrenergic antagonists (e.g., propranolol). * Diagnosed cardiac or neurological conditions, including patients with arrhythmias, heart block, postural orthostatic tachycardia syndrome, Guillain-Barre syndrome, or spinal cord injury. * Active cancer diagnosis * Conditions that may interfere with the ability to understand instructions or complete assessments including: cognitive, or developmental delay. * Patients who do not speak English or French.

Design outcomes

Primary

MeasureTime frame
Validation of analgesia nociception index (ANI) as a tool to assess change in the pain pressure threshold (PTT), measured by the PPT test, of children with chronic pain conditions.6 weeks

Countries

Canada

Contacts

Primary ContactSabrina Carrie, MD
sabrina.carrie@mcgill.ca514-412-4400

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026